D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 86 Citations 87,837 250 World Ranking 502 National Ranking 301
Medicine D-index 94 Citations 96,032 351 World Ranking 4941 National Ranking 2792

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Bacteria
  • Disease

His primary areas of investigation include Sepsis, Septic shock, Immunology, Internal medicine and Intensive care medicine. His specific area of interest is Sepsis, where Steven M. Opal studies Organ dysfunction. His biological study spans a wide range of topics, including Shock, Retrospective cohort study, Intensive care, SOFA score and Endothelium.

He combines subjects such as Gastroenterology, Placebo and Surgery with his study of Internal medicine. His studies deal with areas such as Severe sepsis, Surviving Sepsis Campaign, MEDLINE, ARDS and Disease as well as Intensive care medicine. In his work, Lactate clearance, Sepsis mortality and Pediatric sepsis is strongly intertwined with Sepsis Six, which is a subfield of Surviving Sepsis Campaign.

His most cited work include:

  • Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. (7979 citations)
  • The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (7676 citations)
  • Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 (5443 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Sepsis, Immunology, Intensive care medicine, Septic shock and Internal medicine. His primary area of study in Sepsis is in the field of Organ dysfunction. The various areas that Steven M. Opal examines in his Intensive care medicine study include Severe sepsis, Antibiotics, MEDLINE and Pneumonia.

His Septic shock study combines topics from a wide range of disciplines, such as Disseminated intravascular coagulation and Shock. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Placebo, Surgery and Bacteremia. His Microbiology research incorporates themes from Lipopolysaccharide, Bacterial outer membrane, Escherichia coli and Bacteria.

He most often published in these fields:

  • Sepsis (45.91%)
  • Immunology (35.23%)
  • Intensive care medicine (24.55%)

What were the highlights of his more recent work (between 2014-2021)?

  • Sepsis (45.91%)
  • Intensive care medicine (24.55%)
  • Immunology (35.23%)

In recent papers he was focusing on the following fields of study:

Steven M. Opal mainly focuses on Sepsis, Intensive care medicine, Immunology, Septic shock and Antibiotics. His Sepsis research focuses on Randomized controlled trial and how it relates to Placebo. Steven M. Opal focuses mostly in the field of Intensive care medicine, narrowing it down to matters related to Precision medicine and, in some cases, Clinical research.

His Immunology course of study focuses on Receptor and Pharmacology. His Septic shock research incorporates elements of Randomization, SOFA score and Immune system. As a part of the same scientific study, Steven M. Opal usually deals with the Systemic inflammatory response syndrome, concentrating on Intensive care and frequently concerns with Mortality rate.

Between 2014 and 2021, his most popular works were:

  • The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (7676 citations)
  • Sepsis: a roadmap for future research (540 citations)
  • Sepsis and septic shock (430 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Bacteria

His primary areas of study are Sepsis, Intensive care medicine, Immunology, Septic shock and Placebo. Steven M. Opal studies Systemic inflammatory response syndrome, a branch of Sepsis. His studies in Systemic inflammatory response syndrome integrate themes in fields like Surviving Sepsis Campaign and Sepsis Six.

His research in Intensive care medicine is mostly focused on Intensive care. His research integrates issues of Receptor, Antibiotic resistance and Endothelial dysfunction in his study of Immunology. His Septic shock study combines topics in areas such as Shock, Barrier function, SOFA score, Randomization and Innate immune system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

Dellinger Rp;Levy Mm;Rhodes A;Annane D.
Critical Care Medicine (2013)

14494 Citations

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer;Clifford S. Deutschman;Christopher Warren Seymour;Manu Shankar-Hari.
JAMA (2016)

12078 Citations

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

R. Phillip Dellinger;Mitchell M. Levy;Andrew Rhodes;Djillali Annane.
Intensive Care Medicine (2013)

11720 Citations

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

Mitchell M. Levy;Mitchell P. Fink;John C. Marshall;Edward Abraham.
Critical Care Medicine (2003)

8664 Citations

Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury

John A. Kellum;Norbert Lameire;Peter Aspelin;Rashad S. Barsoum.
Kidney International (2012)

2704 Citations

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

Charles J. Fisher;Jan M. Agosti;Steven M. Opal;Stephen F. Lowry.
The New England Journal of Medicine (1996)

1807 Citations

Anti-Inflammatory Cytokines

Steven M. Opal;Vera A. DePalo.
Chest (2000)

1789 Citations

High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial

Brian L. Warren;Alain Eid;Pierre Singer;Subramanion S. Pillay.
JAMA (2001)

1604 Citations

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

Charles J. Fisher;Jean-Francois A. Dhainaut;Steven M. Opal;John P. Pribble.
JAMA (1994)

1237 Citations

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

Edward Abraham;Konrad Reinhart;Steven Opal;Ignace Demeyer.
JAMA (2003)

1142 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Steven M. Opal

Jean Louis Vincent

Jean Louis Vincent

Université Libre de Bruxelles

Publications: 268

Rinaldo Bellomo

Rinaldo Bellomo

University of Melbourne

Publications: 248

Tom van der Poll

Tom van der Poll

University of Amsterdam

Publications: 215

John A. Kellum

John A. Kellum

University of Pittsburgh

Publications: 192

Derek C. Angus

Derek C. Angus

University of Pittsburgh

Publications: 154

Claudio Ronco

Claudio Ronco

University of Padua

Publications: 140

Evangelos J. Giamarellos-Bourboulis

Evangelos J. Giamarellos-Bourboulis

National and Kapodistrian University of Athens

Publications: 121

Hector R. Wong

Hector R. Wong

Cincinnati Children's Hospital Medical Center

Publications: 114

Marcus J. Schultz

Marcus J. Schultz

University of Amsterdam

Publications: 112

Jeffrey Lipman

Jeffrey Lipman

Royal Brisbane and Women's Hospital

Publications: 109

Marcel Levi

Marcel Levi

University College London Hospitals NHS Foundation Trust

Publications: 104

Mervyn Singer

Mervyn Singer

University College London

Publications: 102

Konrad Reinhart

Konrad Reinhart

Charité - University Medicine Berlin

Publications: 96

John C. Marshall

John C. Marshall

University of Toronto

Publications: 94

Sean M. Bagshaw

Sean M. Bagshaw

University of Alberta

Publications: 93

Peter Pickkers

Peter Pickkers

Radboud University Nijmegen

Publications: 91

Something went wrong. Please try again later.